DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.32 0.61 (0.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $67.32 0.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.67
Previous Close $66.71
Daily Range $66.51 - $68.45
52-Week Range $26.57 - $77.80
Market Cap $8.1B
P/E Ratio -333.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,775,397
Average Daily Volume 2,262,475
Current FY EPS -$0.37




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Biotech Investment Opportunities for the Long Term

Biotech stocks have a history of outperforming the broad-market indexes -- if you pick the right ones. Here are three biotech investment opportunities for the long term that you should be considering.

Can Isis Pharmaceuticals (ISIS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

IWM, GDJJ: Big ETF Outflows

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?


4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

See More ISIS News...

ISIS's Top Competitors

ISIS $67.32 (0.91%)
Current stock: ISIS
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB